September 18, 2023
Trends in Profitability and Compensation of PBMs and PBM Contracting Entities
September 11, 2023
Protected: Nephron Call – CVS Launches Cordavis Biosimilar Subsidiary – Sept. 8th – REPLAY
September 11, 2023
Protected: KOL Call – Impact of Medicaid Redeterminations – Sept. 8th – REPLAY
September 8, 2023
Protected: China Tools & Dx Market Update KOL Call – Sept. 8th – REPLAY
August 18, 2023
Protected: Renal Denervation: What to Expect from FDA Advisory Panel & Reimbursement Outlook – Aug 18th – REPLAY
August 18, 2023
Protected: Market Access Strategies – IQVIA & UPMC Health Plan – Aug 17th – REPLAY
August 18, 2023
Protected: KOL Views on Clinical Trials for CROs & Tools – Aug 16th – REPLAY
August 15, 2023
Protected: Making Sense of Distributor & Pharmacy GLP-1 Trends – Aug. 10th – REPLAY
August 10, 2023
Protected: Nephron GLP-1 Impact Call – August 9th – REPLAY
July 31, 2023
Protected: KOL Call On Current State of Medicare Advantage – July 27 – REPLAY
July 17, 2023
Protected: PBMs in Peril? The 2023 Nephron Research PBM Innovation Symposium – July 11th – REPLAY
July 14, 2023
Protected: Orbitrap vs timsTOF – The Battle for MS Proteomics Supremacy? – July 13th – REPLAY
July 5, 2023
Protected: ADA Takeaways KOL Call – June 28th – REPLAY
July 5, 2023
Protected: KOL Call on Lab/Dx Industry Updates – June 27th – REPLAY
June 23, 2023
Diabetes Week at Nephron – Survey Work, Expert Events, GLP-1’s & More